metformin off-label weight
Selected indexed studies
- Off-label drugs for weight management. (Diabetes Metab Syndr Obes, 2017) [PMID:28652791]
- Metformin. (, 2026) [PMID:30085525]
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. (J Clin Med, 2022) [PMID:36614868]
_Worker-drafted node — pending editorial review._
Connections
metformin off-label weight is a side effect of
Sources
- Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. (2025) pubmed
- Off-label drugs for weight management. (2017) pubmed
- Metformin. (2026) pubmed
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. (2022) pubmed
- Update on off label use of metformin for obesity. (2018) pubmed
- Overview of Diabetes Medications: Traditional and New-Generation Agents and Their Off-Label Use for Weight Loss. (2026) pubmed
- Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m(2) Prior to Bariatric Surgery. (2021) pubmed
- Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis. (2018) pubmed
- Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity. (2024) pubmed
- Is metformin safe in pregnancy: a focus on offspring outcomes. (2025) pubmed